China is already the #3 pharmaceutical market in the world, and the fastest growing. Now, after billions of dollars of investment, China is transforming itself into a world leader in biotechnology. ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on China life science companies and industry events, as well as global issues affecting the China life science market.

Email subscriptions are free. Just click here to register for free daily or weekly summaries of key events in China life science. Paid subscriptions provide full access to all articles and analysis, including over 2000 articles we've published on the industry over the last four years. Click here to learn more about our subscription plans.

Our parent organization, ChinaBio® LLC (www.ChinaBioLLC.com), provides consulting services to major companies and leading investment organizations involved in the China life science industry, including Roche, Pfizer, Life Technolgoies, and many others.  We also provide funding assistance to promising early stage China biotechs through ChinaBio® Capital Partners. We are best known for our seminars and conferences in China, including our annual ChinaBio® Partnering Forum, ChinaBio® Leadership Retreat and our more frequent ChinaBio® Investor Forums (see Upcoming Events).    

Read more about Our Approach, Our Editors and Our Sponsors below...

In This Category

• Our Approach
• Our Editors
• Our Partners